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Skin Exposure to Weak and Moderate Contact
Allergens Induces IFNc Production by Lymph Node
Cells of CD4þ T-Cell-Depleted Mice
Marc Vocanson1,2,3, Anca Hennino2,3, Aurore Rozie`res1,2,3, Magalie Cluzel-Tailhardat2, Gaelle Poyet1,2,3,
Magalie Valeyrie2, Josette Be´netie`re1,2,3, Rosine Te´done2, Dominique Kaiserlian2,3 and
Jean-Franc¸ois Nicolas1,2,3,4
Allergic contact dermatitis (ACD) is mediated by hapten-specific CD8þ T cells and downregulated by CD4þ T
cells. We have recently shown in a model of ACD to weak haptens that priming of IFNg-producing CD8þ T cells
and the development of skin inflammation could be obtained in mice deficient in CD4þ T cells. Here we show
that IFNg production by lymph node (LN) cells draining the site of skin sensitization of CD4þ T-cell-deficient
mice is a marker of the sensitizing properties of weak haptens. LN cells from mice sensitized as in the classical
local lymph node assay (LLNA) were recovered at day 5, then cultured for 20 hours in the presence of
submitogenic doses of phytohemagglutinin, and finally tested for the production of IFNg. Results show that: (i)
production of INFg by LN cells was induced by weak and moderate allergens in a dose-dependent fashion; (ii)
the magnitude of IFNg production paralleled the sensitizing properties of allergens allowing to classify them as
moderate or weak haptens; (iii) chemicals without sensitizing properties were unable to stimulate IFNg
production by LN cells. Therefore, the IFNg LLNA appears as a sensitive, specific, and robust assay to detect
weak contact allergens.
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INTRODUCTION
Allergic contact dermatitis (ACD) is major occupational and
environmental health issue in most industrial countries
(Blauvelt et al., 2003; Saint-Mezard et al., 2004b; Coenraads
and Goncalo, 2007). ACD, also referred to as contact
hypersensitivity (CHS), is a T-cell-mediated skin inflamma-
tory reaction following repeated contact of individuals with
non-protein sensitizing chemicals, called haptens, that is,
contact allergens or contact sensitizers. Depending on the
ability with which haptens induce sensitization on exposed
individuals, they are categorized as strong, moderate, or
weak sensitizers (Gerberick et al., 2004). Although strong
haptens easily sensitize naı¨ve individuals at very low doses,
weak allergens, which comprise most of the chemicals
involved in human ACD, can only induce sensitization in a
small proportion of individuals and at much higher doses.
The pathophysiology of CHS classically involves
two phases, that is, the sensitization and elicitation phases
(Saint-Mezard et al., 2004b). The sensitization phase (afferent
phase) occurs after skin contact with a hapten leading to the
priming of hapten-specific IFNg-producing CD8þ T cells in
the lymph nodes (LNs) draining the site of exposition (Saint-
Mezard et al., 2004a). The elicitation phase occurs when the
sensitized individual is re-exposed to the same allergen.
CD8þ T cells are then recruited and activated at the site of
skin contact, where they initiate the inflammatory process
leading to the cutaneous lesions through IFNg production and
cytotoxity toward keratinocytes (Trautmann et al., 2001;
Akiba et al., 2002). Hence, today it is widely accepted that
IFNg producing CD8þ T cells are the dominant effector
population of CHS which can develop in the absence of
CD4þ T-cell help (Martin, 2004; Saint-Mezard et al.,
2004a; Vocanson et al., 2006b). Moreover, accumulating
evidence has shown that CD4þ T cells (notably the
CD4þCD25þ FoxP3þ T-cell subset (Sakaguchi et al.,
2006)) limit the priming of CD8þ effector T cells in the
draining LNs and participate to the resolution of the skin
inflammatory reaction (Dubois et al., 2003). We recently
demonstrated that CD8þ T cells are effector cells of CHS to
strong haptens as well as to common weak haptens. Whereas
CHS responses to strong haptens, for example DNFB, are
obtained in normal mice, CHS reactions in response to
sensitization to weak haptens occurred only in CD4þ T-cell-
deficient mice, that is, mice deficient in regulatory CD4þ T
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cells (Vocanson et al., 2006b). In this system, CHS to weak
haptens displayed all the features of a classical CHS to
strong haptens and was mediated by IFNg secreting CD8þ
T cells primed in skin-draining LNs, the days following
sensitization.
For many years, hazard identification of skin sensitizers
relied on animal models such as the guinea pig maximization
test, the occluded patch test of Buehler, and the murine ear-
swelling test (Maurer, 2007). Chemicals able to induce a CHS
response are identified as skin sensitizers in those tests. More
recently, the murine local lymph node assay (LLNA) (Kimber
and Dearman, 1991; Kimber et al., 2002) was designed to
appreciate the events occurring during the sensitization phase
in naı¨ve animals. This assay measures the proliferative
response of draining LN cells provoked by repeated topical
application of the test chemical. Hence, the LLNA has
brought tangible benefits for immunotoxicological purposes:
(i) accurate detection of common contact sensitizers that can
be classified according to their sensitization properties
(strong, moderate, weak) (Gerberick et al., 2004); (ii)
reduction of the number of animals used (50%) and
improvement in animal welfare (Kimber et al., 2002).
However, the LLNA features some negative aspects among
which the use of radioactivity and the absence of specificity,
leading to false positive responses with some chemicals
devoid of sensitizing properties but endowed with irritant
pro-inflammatory properties. Moreover, the detection of
chemicals endowed with weak sensitizing activity turned
out to be difficult. Therefore, there is still considerable
interest in improving the alternative methods for detection of
the sensitizing properties of chemicals.
As CHS to common contact allergens is mediated by
hapten-specific IFNg-producing CD8þ T cells and because
IFNg is a cytokine whose production is restricted to activated
T cells, we postulated that production of IFNg by LN T cells
draining the sensitization site could reflect hapten-specific
effector T-cell priming and therefore could be used to
characterize the sensitizing properties of chemicals. We
and others have previously shown that strong haptens like
DNFB, DNCB, or oxazolone potently activate IFNg produc-
tion in LNs, draining the sensitization site in mice using
LLNA-derived protocols (Kehren et al., 1999; Akiba et al.,
2002; Saint-Mezard et al., 2004a; Azam et al., 2005). In
contrast, when weak/moderate haptens were tested, the
magnitude of the IFNg response was routinely low and the
results were poorly reproducible (Azam et al., 2005;
Vocanson et al., 2006b). In the present study, we show that
depletion of CD4þ T cells in weak hapten-sensitized mice
greatly improves the IFNg production by LN cells, in an
LLNA-modified protocol. From this observation, we propose
a new alternative method, referred to as the IFNg LLNA, to
detect common contact allergens.
RESULTS
To study the skin allergenic activity of different chemicals,
wild type (WT) and CD4þ T-cell-depleted BALB/c mice
were sensitized by repeated skin painting (days 0, 1, and 2)
with chemicals on both ears, according to the standard LLNA
protocol (Kimber and Dearman, 1991; OECD and Chemicals
GfT, April 2002). In vivo priming of hapten-induced T cells
was assessed by IFNg-ELISA and -ELISPOT assays performed
on LN cells recovered from immunized mice, and restimu-
lated in vitro with submitogenic doses of phytohemagglutinin
(PHA). This test was named IFNg LLNA.
CD4þ T-cell depletion leads to increased IFNc production by
LN cells of weak hapten-sensitized BALB/c mice
We previously reported that ACD to weak/moderate haptens
is mediated by IFNg-producing CD8þ T cells under the
control of CD4þ T cells endowed with suppressive/
regulatory functions (Vocanson et al., 2006b). Figure 1 shows
CD4þ T-cell depletion of sensitized WT BALB/c mice results
in increased IFNg production by LN cells compared with
undepleted mice. Detectable but very low IFNg
(0.016–0.050 ng ml1) was produced at day 5 by LN cells of
undepleted WT mice sensitized with two common fragrance
allergens (hexylcinnamaldehyde (HCA) and hydroxycitronel-
lal (HDCL)). In contrast, LN cells from mice acutely depleted
in CD4þ T cells produced high quantities of IFNg
(3.595–13.8 ng ml1). Stimulation indices (SI) obtained by
comparison of IFNg production by LN cells from chemical-
sensitized versus vehicle-sensitized mice were respectively 6
and 2 for HCA and HDCL in undepleted mice, and 23 and 7
in CD4þ T-cell-depleted mice. Hence, the detection of the
sensitizing activity of weak sensitizers is dramatically
increased in CD4þ T-cell-depleted mice compared with
normal animals.
Development of the IFNc LLNA
On the basis of the above results, development of the IFNg
LLNA was done using CD4þ T-cell-depleted BALB/c mice
only and HCA which is a recommended LLNA positive
control (Dearman et al., 2001). Figure 2 shows the
dose–response effect of PHA on IFNg production by LN cells
of HCA- and vehicle-sensitized mice, in a 20 hours culture
system. IFNg secretion of LN cells from vehicle (acetone/olive
oil (A/OO, 4:1))-painted mice increased mildly with PHA
concentration and reached a plateau at high mitogenic doses
(Figure 2a and b). In contrast, the production of IFNg by LN
cells from HCA-sensitized mice increased dramatically with
PHA concentration, reached a plateau at 20mg ml1 and
dropped at 40 mg ml1 (Figure 2a and b). Time-course
experiments indicated that IFNg secretion rose progressively
in the first hours of PHA stimulation was maximal at about
20 hours and decreased in the following hours (Figure 2c).
As expected, SI inversely correlated with the concentration
of PHA (Figure 2b). Indeed, at high doses, PHA exerts
mitogenic activity toward the entire LN T-cell subset leading
to non-specific IFNg production. In contrast, at low (sub-
mitogenic) doses below 10 mg ml1, PHA was able to induce
IFNg production by LN cells that had been activated in vivo
only, suggesting that the response obtained with HCA reflects
the activation of in vivo hapten-induced T cells.
Finally, the kinetics of the HCA-induced T-cell response
was monitored at different days after sensitization by IFNg-
ELISPOT. IFNg spot-forming cells (SFCs) were detected as
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soon as day 3, peaked at day 5, and decreased in the
following days (Figure 2d).
Of note, similar results, including dose and time-course
responses, were obtained with another mitogenic agent for T
cells, that is, anti-CD3 monoclonal antibody (mAb) (2c11
clone) used at submitogenic concentrations (Figure S2).
From the above data, the following parameters were
chosen for the test: (i) LN cells are recovered at day 5 post-
mAb treatment
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Figure 1. IFNc production by LN cells is dramatically increased in CD4þ T-cell-depleted mice compared with normal mice on hapten sensitization. Normal
or CD4þ T-cell-depleted BALB/c mice were sensitized on both ears for three consecutive days (days 0, 1, 2) by applications of 25% (w/v) HCA, 25%
(w/v) hydroxycitronellal (HDCL), or the vehicle A/OO. At day 5, draining LN cells were collected and cultured ex vivo in presence of 5 mg ml1 PHA for
20 hours. IFNg secretion was titrated by ELISA. Results are represented as raw data and histograms. Stimulation indices obtained by comparison of IFNg
production by LN cells from chemical-sensitized versus vehicle-sensitized mice (SI¼ IFNg secretion for HCA or HDCL-sensitized mice/IFNg secretion for
AOO sensitized-mice) are reported. Results are representative of three different experiments with 4 mice per group.
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Figure 2. Development of the IFNc LLNA in CD4þ T-cell-depleted mice. (a, b) Influence of the PHA concentration on IFNg secretion. CD4þ T-cell-depleted
BALB/c mice were sensitized on both ears for three consecutive days (days 0, 1, and 2) by applications of 25% (w/v) HCA (K) or the vehicle A/OO (’).
At day 5, draining LN cells were collected and cultured ex vivo for 20 hours in presence of different concentrations of PHA. INFg secretion was measured by
ELISA assay. Results are represented as graph (a) and raw data (b). Stimulation indices obtained by comparison of IFNg production by LN cells from HCA-
sensitized versus vehicle-sensitized mice (SI¼ IFNg secretion for HCA-sensitized mice/IFNg secretion for AOO sensitized-mice) are reported (b). Results are
representative of three different experiments with four mice per group. (c) Influence of the time of PHA stimulation on IFNg secretion. CD4þ T-cell-depleted
BALB/c mice were sensitized as described above by applications of 25% (w/v) HCA (K) or the vehicle A/OO (’). At day 5, draining LN cells were collected and
cultured ex vivo in presence of 5 mg ml1 PHA for different intervals of time. IFNg secretion was titrated by ELISA assay. Results are representative of three
different experiments with four mice per group. (d) Kinetics of the HCA-induced T-cell response. CD4þ T-cell-depleted BALB/c mice were sensitized on both
ears for three consecutives days (days 0, 1, and 2) by applications of 25% (w/v) HCA. At different intervals of time after the first sensitization, draining LN cells
were collected and cultured ex vivo with 5 mg ml1 of PHA. IFNg spot-forming cells (SFCs) were determined after 20 hours of cell culture. Results are
representative of three different experiments with four mice per group.
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sensitization; (ii) 5 mg ml1 is the dose of PHA inducing IFNg
production by sensitized mice but not vehicle-treated mice;
(iii) as ELISA and ELISPOT gave similar results (Figure S3),
ELISA was chosen for the detection of IFNg production by LN
cells because it is easier to perform than ELISPOT.
Inter-experiment standardization of the IFNc LLNA results
During the development of the test, we observed that the
magnitude of IFNg secretion by LN cells of vehicle- and
HCA-painted mice varied greatly, but in similar proportions,
from one experiment to another. Therefore, in order to
compare results obtained from different experiments, HCA
was introduced in each experiment and the results recorded
for test haptens were expressed as a percentage of the HCA
response. All chemicals were tested at a concentration of
25% (w/v) except sodium lauryl sulfate (SLS), which was used
at 10% (w/v) (it was not soluble at higher doses in the two
vehicles—A/OO or N,N,-dimethylformamide (DMF)—used
in this study). Respective molar concentrations were:
isoeugenol (1.52 M), HCA (1.16 M), dihydrocoumarin (DHC)
(1.59 M), lyral (1.19 M), methyl octine carbonate (MOC)
(1.49 M), eugenol (1.52 M), HDCL (1.45 M), lilial (1.22 M),
geraniol (1.62 M), coumarin (1.71 M), SLS (0.35 M), isopropa-
nol (ISOP) (4.16 M), and methyl salicylate (MS) (1.64 M).
The IFNc LLNA detects the sensitizing properties of weak
haptens
Several groups of chemicals were tested in the IFNg LLNA: (i)
non-sensitizers (ISOP, MS, SLS); (ii) weak haptens (eugenol,
geraniol, HDCL, lilial, lyral, MOC, coumarin), and (iii)
moderate haptens (isoeugenol, HCA, DHC).
The IFNg LLNA responses, that is, IFNg production by
PHA-restimulated LN cells, induced by ear painting of
different moderate/weak haptens, were dose-dependent
(Figure 3). Conversely, responses induced by increasing
doses of the non-sensitizer MS only slightly exceeded the
response induced by the vehicle A/OO.
Interestingly, the IFNg LLNA responses induced by
non-sensitizers (ISOP, MS, SLS) and by the vehicles (A/OO
and DMF) always represented less than 15 and 5% of
that induced by HCA, respectively. Therefore, a threshold
value of 15% of the HCA-induced IFNg LLNA response was
chosen to identify chemicals endowed with sensitizing
properties.
In this context, all the weak sensitizers tested gave positive
responses in the test (Figure 4). Isoeugenol, lyral, methyl
octine carbonate, eugenol, DHC, HDCL, and lilial provoked
a mean response of 158, 58, 59, 33, 30, 36, and 30% of the
HCA response, respectively. Similar results, following the
same hierarchy between these molecules, were obtained
from three different experiments, demonstrating the reprodu-
cibility of the method.
Coumarin and geraniol, postulated to be weak haptens,
were not classified as contact sensitizers in the IFNg LLNA as
they did not reach the threshold value of 15%.
DISCUSSION
We have previously shown, in a mouse model of fragrance
allergy, that CD8þ T cells are effector cells of ACD to
common weak allergens and are under the control of CD4þ
T regulatory cells, which prevent their priming in vivo.
Indeed, ACD to fragrances was obtained in CD4þ T-cell-
depleted mice but not in normal mice. These observations
suggested that mice deficient in CD4þ T cells could be used
to detect the immunizing properties of chemicals.
In this study, we used the fragrance allergy mouse model
to develop a non-radioactive LLNA-derived assay, referred to
as the IFNg LLNA, to detect the skin-sensitizing properties of
chemicals. The skin of CD4þ T-cell-deficient mice was
painted with chemicals and the priming of CD8þ T cells in
the draining LNs was assessed by IFNg production on
restimulation by submitogenic doses of PHA. The rationale
for using IFNg production as the read-out of hapten-induced
T-cell priming comes from previous studies from our group,
and others, that have shown that hapten-specific CD8þ
effector T cells produce high amounts of IFNg (Xu et al.,
1996; Kehren et al., 1999; Akiba et al., 2002). Depletion of
CD8þ T cells abrogated the IFNg production in LN cells,
demonstrating that CD8þ T cells were the only IFNg-
producing cell type during hapten sensitization (Kehren et al.,
1999; Akiba et al., 2002). Therefore, the measurement of
IFNg in draining LNs represents a direct means of studying
hapten-specific effector T-cell priming. The rationale for
using submitogenic doses of PHA for the detection of hapten-
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Figure 3. Dose responses induced by different chemicals in the IFNc LLNA. CD4þ T-cell-depleted BALB/c mice were sensitized on both ears for three
consecutive days (days 0, 1, and 2) by different concentrations of chemicals or by the vehicle A/OO. At day 5, draining LN cells were collected and cultured ex
vivo in presence of 5mg ml1 PHA for 20 hours. IFNg secretion was evaluated by ELISA. Results are representative of three different experiments with four mice
per group.
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specific T cells comes from previous immunological studies
on antigen-specific T-cell responses. Indeed, at low doses,
mitogens cannot activate resting and naı¨ve T cells but can
potently stimulate proliferation and activation of in vivo pre-
activated T cells (Cohen et al., 1974). This protocol is
particularly well suited for the study of in vitro T cell
responses to contact allergens, as most of the weak haptens
are lipophilic molecules, which cannot be incorporated into
culture media for secondary T-cell proliferative responses. In
this study, we monitored the IFNg secretion by LN cells of
hapten-sensitized mice using submitogenic doses of PHA, or
anti-CD3 mAb, in an ex vivo secondary T-cell response.
Our results show that the IFNg LLNA, that is production of
IFNg by LN cells of CD4þ T-cell-deficient mice, represents a
sensitive, specific, and robust assay to appreciate the
sensitizing properties of chemicals. First, all tested chemicals
known to be contact allergens in humans (except Geraniol
and Coumarin) induced IFNg production in the assay.
Second, none of the chemicals endowed with irritant, but
not with allergenic, properties were able to trigger IFNg
secretion by LN cells. This suggests that the IFNg LLNA is
more specific than the radioactive LLNA, where the non-
sensitizer SLS induces frequent positive reactions. The reason
for the high specificity of the IFNg LLNA probably relies on
the fact that IFNg production reflects activation of specific
CD8þ T cells. In contrast, the radioactive LLNA measures
LN cell proliferation, which may involve specific and non-
specific LN cells. Third, the magnitude of IFNg production
paralleled the sensitizing properties of chemicals. Indeed, the
moderate allergens isoeugenol and HCA gave consistently
higher IFNg production than the weak allergens eugenol,
lilial, HDCL, or lyral. We report (Table S1) the EC3 values
obtained for each sensitizer in a standard LLNA that serve to
rank the sensitizing potency of contact allergens (Gerberick
et al., 2004; ICCVAM, 2008). Analysis of our results shows a
good correlation between the magnitude of IFNg production
obtained in the IFNg LLNA and the EC3 values, except for
DHC that gave weaker responses in the IFNg LLNA than in
the standard LLNA.
Geraniol and coumarin were the only two weak allergens
that did not induce T-cell priming in CD4þ T-cell-deficient
mice. This suggests either that our assay is not sensitive
enough to detect very weak haptens or that the two chemicals
tested here have no sensitizing properties. In this respect, it is
noteworthy that coumarin per se is not a contact sensitizer as
we have recently reported that pure coumarin is unable to
induce sensitization in a fragrance allergy mouse model
(Vocanson et al., 2007) and to reveal coumarin allergy in
humans (Vocanson et al., 2006a). In contrast, less pure
coumarin preparations containing derivatives and contami-
nants, such as DHC, which scored positive in the IFNg LLNA,
may promote sensitization and allergy. Whether a similar
hypothesis may explain why geraniol did not induce IFNg
production in the modified LLNA remains to be tested.
IFNg production was already used as an endpoint to
screen for sensitizers in LLNA-derived protocols in normal
mice (Dearman et al., 1999; Azam et al., 2005). However,
the investigators gave low credit to this strategy because the
results showed poor sensitivity (Dearman et al., 1999) and
high variability (Azam et al., 2005). The poor sensitivity was
probably related to the presence, in normal mice, of CD4þ T
cells with suppressive activity that prevented the priming of
and IFNg production by CD8þ effector T cells. Indeed, as
shown by the present study, depletion of CD4þ T cells
before sensitization dramatically increased IFNg production
leading to a very sensitive IFNg LLNA (Figure 1). Similarly to
the results recorded by Azam et al. (2005), we observed that
the magnitude of IFNg secretion in the test varied greatly from
one experiment to another. However, to avoid the negative
impact of this variability for a potency-based classification of
sensitizers, we introduced a positive control in each
experiment and the results recorded for test haptens were
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Figure 4. Use of the IFNc LLNA test to detect the sensitizing properties of weak haptens. CD4þ T-cell-depleted BALB/c mice were sensitized by different
chemicals on both ears for three consecutive days (days 0, 1, and 2). All the molecules were tested at 25% (w/v) concentration, except SLS (10% (w/v)) and the
vehicles A/OO and DMF. At day 5, draining LN cells were collected and cultured ex vivo in presence of 5 mg ml1 PHA for 20 hours. IFNg secretion was titrated
by ELISA. INFg secretion induced by the different chemicals was compared with that obtained with HCA in three different experiments, with four mice per
group, and the results were expressed as mean of the percentage of the HCA response. The plain line represents the IFNg production induced by HCA
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expressed as a percentage of the positive control response.
Interestingly, in that experimental setting, repetition of the
experiments always led to similar categorization of chemi-
cals, indicating that the IFNg LLNA is not only useful for
detecting contact allergens but is robust enough to assess and
classify their respective sensitizing potency.
In conclusion, we demonstrate here that the IFNg LLNA
accounts for a promising non-radioactive alternative test to
detect immune responses induced by common chemicals
endowed with skin sensitizing properties. Our results need to
be validated with other sensitizers and by inter-laboratory
experiments, notably to determine a precise threshold value
that could discriminate between weak allergens and non-
sensitizers.
MATERIALS AND METHODS
Mice
Female BALB/c mice were purchased from Charles River Labora-
tories (L’Arbresle, France). Animals were left to acclimatize before
entering the study and were provided with food and water ad
libidum. All the mice were used between 8 and 10 weeks of age.
Experimental procedures were approved by the institutional review
board on animal experiments (Comite´ Re´gional d’Ethique sur
l’Expe´rimentation Animale).
Chemicals
DHC (98% pure), geraniol (98% pure), a-HCA (85% pure), HDCL
(95% pure), isoeugenol (98% pure), SLS (99% pure), and MS (99%
pure) were purchased from Sigma-Aldrich (Saint Quentin en
Fallavier, France). Eugenol, lyral, lilial, and MOC were purchased
from Firmenich (Neuilly sur Seine, France) and ISOP (99.7% pure)
from Merck. Coumarin (Rhodiascent extra pure, 499.9% pure) was
produced in Rhodia Organics (Lyon, France). All the chemicals were
prepared in A/OO (Carlos Erba and Lessieur) (4:1, v/v) freshly before
application, except for SLS, DHC, and coumarin, which were
dissolved in DMF (Sigma). Chemicals were dispensed with gloves for
dermal protection.
Antibody depletion of CD4þ T cells in vivo
The rat anti-mouse CD4 mAb GK 1.5 was obtained from ATCC
(Rockville, MD). Hybridomas were grown as ascites in pristane-
primed Swiss-nude mice. Mice were given i.p. injections of 20 mg of
anti-CD4 mAbs in 200ml on days 1, 0, 1, and 4. Depletions 498%
were observed in all the experiments (Figure S1).
Sensitization of mice
The sensitization procedure was conducted according to the
standard LLNA protocol (Kimber and Dearman, 1991; OECD and
Chemicals GfT, April 2002). Briefly, groups of BALB/c mice (n¼ 3–4)
were painted by topical application of 25ml per ear of the
appropriate dilution of the test substance, or of vehicle alone, on
the dorsum of both ears, daily for three consecutive days (days 0, 1,
and 2).
Preparation of draining LN cells
The days following chemical application, draining auricular LNs
were collected in complete RPMI medium (RPMI 1640 supplemen-
ted with 10% heat-inactivated fetal calf serum, 2 mM L-glutamine,
100mg ml1 streptomycin, 100 U ml1 ampicillin and 5 105 M of
b-2 mercaptoethanol) and pooled per experimental group. A single-
cell suspension of LN cells was prepared by mechanical disaggrega-
tion through a 100mm nylon filter (Becton Dickinson, Le Pont de
Claix, France). Viable cell counts were carried out by exclusion of
0.5% trypan blue and dilutions of LN cells were prepared in
complete RPMI medium.
Analysis of chemical-induced T-cell responses
IFNc-ELISPOT. The number of IFNg-producing cells in the
draining LNs of mice sensitized by chemicals was determined using
an ELISPOT assay. Briefly, 96-well nitrocellulose plates (MAIP
N4510; Millipore, Saint Quentin-en-Yvelines, France) were wet with
70% ethanol for 10 minutes, washed in phosphate buffer saline and
coated overnight at 4 1C with an anti-IFNg antibody (R46A2; BD-
Pharmingen, Le Pont de Claix, France). The following day, the plates
were blocked with phosphate buffer saline/1% bovine serum
albumin for 2 hours at 37 1C, and they were washed five times
with phosphate buffer saline/Tween 0.05% before use. Auricular
LN cells were then dispensed in the plates (105 per well) and
incubated in presence of phytohemagglutinin-P (PHA-P; Sigma)
overnight at 37 1C, 5% CO2. After washing, plates were incubated
2 hours at 37 1C, 5% CO2 with a biotinylated anti-IFNg antibody
(XMG1.2; BD-Pharmingen). IFNg SFCs were developed using Avidin
Horse Radish Peroxydase (CliniSciences, Montrouge, France)
incubated for 20 minutes at room temperature, and extensively
washed before adding the substrate (aminoethyl carbazole; Sigma).
The number of IFNg SFCs present in each well was counted using
the Carl Zeiss vision ELISPOT (Carl Zeiss Vision, D-85399,
Hallberghoos, Germany) and the results were expressed as IFNg
SFCs/105 LN cells.
IFNg-ELISA. Secretion of IFNg-producing cells in the draining LNs
of mice sensitized by chemicals was determined by ELISA. A total of 2
million LN cells ml1 were cultured, in duplicate or triplicate, in 96-
well plates in RPMI complete medium, in the presence of PHA-P, or in
the presence of an anti-CD3-mAb (2c11; BD-Pharmingen), at 37 1C,
5% CO2. Of note, the same batch of PHA was used for all the
experiments. Cell-free supernatants were harvested after 16–48 hours,
and IFNg production was titrated by ELISA using the R&D System (Lille,
France) DuoSet kit following the manufactural protocol.
Statistics
Statistics were performed using a one-way analysis of variance test to
compare groups of chemicals. Po0.01% was used as the level of
significance.
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SUPPLEMENTARY MATERIAL
Figure S1. In vivo treatment of BALB/c mice with anti-CD4 mAb leads to
profound CD4þ T-cell depletion in lymphoid organs.
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Figure S2. Development of the IFNg LLNA in CD4þ T-cell-depleted mice.
Anti-CD3 mAb restimulation.
Figure S3. Detection of chemical-induced T-cell responses by IFNg-ELISA and
IFNg-ELISPOT techniques.
Table S1. LLNA EC3 values (from the NICEATM database) and sensitizing
potency for the test chemicals.
REFERENCES
Akiba H, Kehren J, Ducluzeau MT, Krasteva M, Horand F, Kaiserlian D et al.
(2002) Skin inflammation during contact hypersensitivity is mediated by
early recruitment of CD8+ T cytotoxic 1 cells inducing keratinocyte
apoptosis. J Immunol 168:3079–87
Azam P, Peiffer JL, Ourlin JC, Bonnet PA, Tissier MH, Vian L et al. (2005)
Qualitative and quantitative evaluation of a local lymph node assay
based on ex vivo interleukin-2 production. Toxicology 206:285–98
Blauvelt A, Hwang ST, Udey MC (2003) 11. Allergic and immunologic
diseases of the skin. J Allergy Clin Immunol 111:S560–70
Coenraads PJ, Goncalo M (2007) Skin diseases with high public health
impact. Contact dermatitis. Eur J Dermatol 17:564–5
Cohen MH, Chretien PB, Felix EL, Loyd BC, Ketcham AS, Albright LA et al.
(1974) Augmentation of lymphocyte reactivity in guinea pigs, mice,
monkeys and humans sensitised to BCG, dinitrochlorobenzene or
nitrogen mustard. Nature 249:656–8
Dearman RJ, Hilton J, Basketter DA, Kimber I (1999) Cytokine endpoints for
the local lymph node assay: consideration of interferon-gamma and
interleukin 12. J Appl Toxicol 19:149–55
Dearman RJ, Wright ZM, Basketter DA, Ryan CA, Gerberick GF, Kimber I
(2001) The suitability of hexyl cinnamic aldehyde as a calibrant for the
murine local lymph node assay. Contact Dermatitis 44:357–61
Dubois B, Chapat L, Goubier A, Kaiserlian D (2003) CD4+CD25+ T cells as
key regulators of immune responses. Eur J Dermatol 13:111–6
Gerberick GF, Ryan CA, Kern PS, Dearman RJ, Kimber I, Patlewicz GY et al.
(2004) A chemical dataset for evaluation of alternative approaches to
skin-sensitization testing. Contact Dermatitis 50:274–88
ICCVAM (2008) Draft ICCVAM Background Review Document: Use of the
Murine Local Lymph Node Assay (LLNA) to Determine Skin Sensitization
potency Categories. Research Triangle Park, NC: National Toxicology
Program. Available http://iccvam.niehs.nih.gov/methods/immunotox/
llna-BRD.htm
Kehren J, Desvignes C, Krasteva M, Ducluzeau MT, Assossou O, Horand F
et al. (1999) Cytotoxicity is mandatory for CD8(+) T cell-mediated
contact hypersensitivity. J Exp Med 189:779–86
Kimber I, Dearman RJ (1991) Investigation of lymph node cell proliferation as
a possible immunological correlate of contact sensitizing potential. Food
Chem Toxicol 29:125–9
Kimber I, Dearman RJ, Basketter DA, Ryan CA, Gerberick GF (2002) The local
lymph node assay: past, present and future. Contact Dermatitis
47:315–28
Martin SF (2004) T lymphocyte-mediated immune responses to chemical
haptens and metal ions: implications for allergic and autoimmune
disease. Int Arch Allergy Immunol 134:186–98
Maurer T (2007) Guinea pigs in hypersensitivity testing. Methods 41:
48–53
OECD and Chemicals GfT (April 2002) Draft New Guideline 429 ‘‘skin
sensitization: Local Lymph Node Assay’’
Saint-Mezard P, Berard F, Dubois B, Kaiserlian D, Nicolas JF (2004a) The role
of CD4+ and CD8+ T cells in contact hypersensitivity and allergic
contact dermatitis. Eur J Dermatol 14:131–8
Saint-Mezard P, Rosieres A, Krasteva M, Berard F, Dubois B, Kaiserlian D
et al. (2004b) Allergic contact dermatitis. Eur J Dermatol 14:
284–295
Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z et al. (2006)
Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-
tolerance and autoimmune disease. Immunol Rev 212:8–27
Trautmann A, Akdis M, Schmid-Grendelmeier P, Disch R, Brocker EB, Blaser
K et al. (2001) Targeting keratinocyte apoptosis in the treatment of atopic
dermatitis and allergic contact dermatitis. J Allergy Clin Immunol
108:839–46
Vocanson M, Goujon C, Chabeau G, Castelain M, Valeyrie M, Floc’h F et al.
(2006a) The skin allergenic properties of chemicals may depend on
contaminants—evidence from studies on coumarin. Int Arch Allergy
Immunol 140:231–8
Vocanson M, Hennino A, Cluzel-Tailhardat M, Saint-Mezard P, Benetiere J,
Chavagnac C et al. (2006b) CD8+ T cells are effector cells of contact
dermatitis to common skin allergens in mice. J Invest Dermatol
126:815–20
Vocanson M, Valeyrie M, Rozieres A, Hennino A, Floc’h F, Gard A et al.
(2007) Lack of evidence for allergenic properties of coumarin in a
fragrance allergy mouse model. Contact Dermatitis 57:361–4
Xu H, DiIulio NA, Fairchild RL (1996) T cell populations primed by hapten
sensitization in contact sensitivity are distinguished by polarized patterns
of cytokine production: interferon gamma-producing (Tc1) effector
CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative
regulatory CD4+ T cells. J Exp Med 183:1001–12
www.jidonline.org 1191
M Vocanson et al.
Skin Exposure to Allergens
